Trientine Compassionate Use Program
15 April 2010
Univar Ltd is pleased to announce that with effect from March 1st 2010, qualified patients in designated territories around the world could benefit from the compassionate use program of Trientine Dihydrochloriede 300mg capsules.
Univar sponsors this donation scheme through our partnership with Wilson Disease Association (WDA) International. Patients should make their request to mary.graper@wilsondisease.org.
Univar Ltd is committed to Wilson disease patients and our new compassionate use program is yet another step we have taken to help ease some of the worries and burden on patients and families in the management of the condition.